Xu R, Huang MJ, Jiang ZH, Liu L, et al. Neoadjuvant Anlotinib Plus Paclitaxel-Cisplatin for Technically Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Single-Arm Phase II Study. Head Neck 2026 Sep 30. doi: 10.1002/hed.70501.
PMID: 42816421